These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9064953)

  • 21. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
    Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone: what have we learned from clinical trials?
    Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
    Clin Cardiol; 2000 Feb; 23(2):73-82. PubMed ID: 10676597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    Int J Cardiol; 2008 May; 126(1):101-7. PubMed ID: 17499864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
    Rea RS; Kane-Gill SL; Rudis MI; Seybert AL; Oyen LJ; Ou NN; Stauss JL; Kirisci L; Idrees U; Henderson SO
    Crit Care Med; 2006 Jun; 34(6):1617-23. PubMed ID: 16614583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pederson C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    J Hypertens; 2007 Feb; 25(2):307-13. PubMed ID: 17211237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".
    Ayalloore SG; LeLorier P
    Circulation; 2011 Apr; 123(14):e404; author reply e405. PubMed ID: 21482971
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of amiodarone in the postmyocardial infarction patient.
    Ozdil E; Carlson TA; Massumi A
    Tex Heart Inst J; 1995; 22(1):40-3. PubMed ID: 7787469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive prediction of sudden death and sustained ventricular tachycardia after acute myocardial infarction using a neural network algorithm.
    Zoni-Berisso M; Molini D; Viani S; Mela GS; Delfino L
    Ital Heart J; 2001 Aug; 2(8):612-20. PubMed ID: 11577836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
    Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
    Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F; Lepera G; Rolli A
    Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.